The latest closing stock price for Quince Therapeutics as of January 21, 2025 is 1.48.
An investor who bought $1,000 worth of Quince Therapeutics stock at the IPO in 2019 would have $-955 today, roughly -1 times their original investment - a -40.36% compound annual growth rate over 6 years.
The all-time high Quince Therapeutics stock closing price was 120.21 on August 10, 2021.
The Quince Therapeutics 52-week high stock price is 2.45, which is 65.5% above the current share price.
The Quince Therapeutics 52-week low stock price is 0.51, which is 65.5% below the current share price.
The average Quince Therapeutics stock price for the last 52 weeks is 1.11.
An investor who bought $1,000 worth of Quince Therapeutics stock at the IPO in 2019 would have $-955 today, roughly -1 times their original investment - a -40.36% compound annual growth rate over 6 years.
The all-time high Quince Therapeutics stock closing price was 120.21 on August 10, 2021.
The Quince Therapeutics 52-week high stock price is 2.45, which is 65.5% above the current share price.
The Quince Therapeutics 52-week low stock price is 0.51, which is 65.5% below the current share price.
The average Quince Therapeutics stock price for the last 52 weeks is 1.11.